| abstract |
The present invention provides a pharmaceutical formulation comprising voriconazole or a pharmaceutically acceptable derivative thereof, and a cyclodextrin derivative of formula (I) or a pharmaceutically acceptable salt thereof.n n n <Formula I>n n n n n n n n Wherein R 1a -g , R 2a -g and R 3a -g independently represent OH or O (CH 2 ) 4 SO 3 H. |